Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luteon is a pharmaceutical brand of progesterone, an endogenous steroid hormone essential for the regulation of the female reproductive system and the maintenance of pregnancy. Developed and manufactured by Shin Poong Pharmaceutical, it is primarily indicated for conditions associated with progesterone deficiency, including primary and secondary amenorrhea, functional uterine bleeding, and as luteal phase support in assisted reproductive technology (ART). Progesterone acts as an agonist at the progesterone receptor (PR); upon binding, it induces the secretory transformation of the estrogen-primed endometrium, facilitates embryo implantation, and maintains gestation by reducing uterine contractility. Luteon is typically formulated as an oil-based solution for intramuscular injection, providing a sustained therapeutic effect to support reproductive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Luteon.